{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:08:00Z","timestamp":1759018080256,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jinf.2005.05.010","type":"journal-article","created":{"date-parts":[[2005,6,30]],"date-time":"2005-06-30T12:05:14Z","timestamp":1120133114000},"page":"188-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand"],"prefix":"10.1016","volume":"52","author":[{"given":"S.","family":"Sungkanuparph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Manosuthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vibhagool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.05.010_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199101313240503","article-title":"Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection","volume":"324","author":"Small","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2005.05.010_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/339448","article-title":"Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991\u20132000","volume":"34","author":"Leonard","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib3","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1097\/00002030-200312050-00008","article-title":"Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy","volume":"17","author":"Hung","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.05.010_bib4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/520275","article-title":"Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for HIV-related pulmonary tuberculosis","volume":"26","author":"El-Sadr","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.05.010_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/515174","article-title":"Therapeutic implications of drug interactions in the treatment of HIV-related tuberculosis","volume":"28","author":"Burman","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1164\/ajrccm\/136.3.570","article-title":"Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival","volume":"136","author":"Chaisson","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2005.05.010_bib9","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/424676","article-title":"Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy","volume":"190","author":"Dheda","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/1087291041444069","article-title":"Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients","volume":"18","author":"Kwara","year":"2004","journal-title":"AIDS Patient Care STDs"},{"issue":"RR-20","key":"10.1016\/j.jinf.2005.05.010_bib11","first-page":"1","article-title":"Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations","volume":"47","year":"1998","journal-title":"MMWR"},{"key":"10.1016\/j.jinf.2005.05.010_bib12","first-page":"185","article-title":"Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors","volume":"49","year":"2000","journal-title":"MMWR"},{"key":"10.1016\/j.jinf.2005.05.010_bib13","first-page":"37","article-title":"Notice to readers: updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors","volume":"52","year":"2004","journal-title":"MMWR"},{"year":"2003","series-title":"Treatment of tuberculosis: guidelines for national programmes","key":"10.1016\/j.jinf.2005.05.010_bib14"},{"key":"10.1016\/j.jinf.2005.05.010_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV\/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity","volume":"306","author":"Ward","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jinf.2005.05.010_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.98.12020505","volume":"12","author":"Veen","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2005.05.010_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1468-1293.2002.00104.x","article-title":"HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of <50cells\/microL): an analysis of 338 clinical events from a randomized clinical trial","volume":"3","author":"Floridia","year":"2002","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2005.05.010_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0213-005X(04)73054-2","article-title":"Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy","volume":"22","author":"Reus","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jinf.2005.05.010_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200241090-00004","article-title":"Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis","volume":"41","author":"Lopez-Cortes","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jinf.2005.05.010_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/ajrccm.164.1.2101133","article-title":"Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy","volume":"164","author":"Burman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"year":"2004","series-title":"Scaling up antiretroviral therapy in resource-limited settings: treatment guideline for a public health approach","key":"10.1016\/j.jinf.2005.05.010_bib21"},{"key":"10.1016\/j.jinf.2005.05.010_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-1293.2004.00195.x","article-title":"Nevirapine-versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naive patients with advanced HIV infection","volume":"5","author":"Manosuthi","year":"2004","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2005.05.010_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00126334-200305010-00019","article-title":"Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis","volume":"33","author":"Sungkanuparph","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2005.05.010_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/00365549950163842","article-title":"Clinical presentation of tuberculosis and the degree of immunodeficiency in patients with HIV infection","volume":"31","author":"Lado Lado","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","article-title":"Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection","volume":"148","author":"Jones","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jinf.2005.05.010_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003495-198224020-00002","article-title":"Short-course therapy for tuberculosis","volume":"24","author":"Aquinas","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.jinf.2005.05.010_bib27","first-page":"1182","article-title":"Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report)","volume":"1","author":"Somner","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2005.05.010_bib28","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/00002030-199910010-00012","article-title":"Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons","volume":"13","author":"Sterling","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.05.010_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","article-title":"Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998","volume":"53","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2005.05.010_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2005.05.010_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1378\/chest.120.1.193","article-title":"Paradoxical worsening of tuberculosis in HIV-infected patients","volume":"120","author":"Wendel","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2005.05.010_bib32","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00002030-200309260-00018","article-title":"Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis","volume":"17","author":"Sungkanuparph","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.05.010_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2003.09.001","article-title":"AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection","volume":"48","author":"Lawn","year":"2004","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2005.05.010_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00002030-200404300-00004","article-title":"START project. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care","volume":"18","author":"Abdool-Karim","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.05.010_bib35","doi-asserted-by":"crossref","first-page":"A11","DOI":"10.1111\/j.1365-3156.2004.01259.x","article-title":"Integrating tuberculosis and HIV care in the primary care setting in South Africa","volume":"9","author":"Coetzee","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jinf.2005.05.010_bib36","first-page":"24","article-title":"New nevirapine label underscores the risk for hepatotoxicity in key populations","volume":"16","year":"2004","journal-title":"AIDS Clin Care"},{"key":"10.1016\/j.jinf.2005.05.010_bib37","unstructured":"Dear Health Care Professional Letter. \u2018Clarification of risk factors for severe, life-threatening and fatal hepatotoxicity with VIRAMUNE\u00ae (nevirapine)\u2019, Boehringer Ingelheim; 2004."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:43Z","timestamp":1758986983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0163445305001398"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.05.010","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}